Advanced Biomed Inc (ADVB)

NASD · Healthcare · Diagnostics & Research · Taiwan

Advanced Biomed Inc is a micro cap company (market value under $300 million) in the Diagnostics & Research industry.

Advanced Biomed Inc develops microfluidic technology platforms and medical devices for cancer detection. The company designs and manufactures equipment and biochips that detect circulating tumor cells and tumor markers in blood samples for screening, diagnosis, and treatment monitoring. Products include devices like AC-1000 and A+CellScan, with operations in Taiwan and Hong Kong.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Advanced Biomed Inc stock.

Our verdict on ADVB

Not valued: We cannot value this company yet.

Browse

Stocks in Taiwan

Peers in Diagnostics & Research

All 44 Diagnostics & Research stocks

Cheaper than ADVB in Diagnostics & Research

Biodesix Inc (BDSX): fairly valued, 2% margin of safety
Quest Diagnostics Inc (DGX): slightly overvalued, -9% margin of safety
GeneDx Holdings Corp (WGS): slightly overvalued, -11% margin of safety
Exagen Inc (XGN): slightly overvalued, -20% margin of safety
Fulgent Genetics Inc (FLGT): overvalued, -28% margin of safety
Medpace Holdings Inc (MEDP): overvalued, -30% margin of safety

23 more in this industry show a wider margin of safety.

Is ADVB undervalued or overvalued?

We do not publish a verdict on ADVB yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of ADVB?

We do not publish one (as of the 2026-10-30 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.